Award details

Genetic and immunological safety of DNA vaccines

ReferenceBBS/E/I/00000386
Principal Investigator / Supervisor Dr Geraldine Taylor
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 90,053
StatusCompleted
TypeInstitute Project
Start date 01/04/1997
End date 30/09/1999
Duration30 months

Abstract

RSV is the single most common cause of viral bronchiolitis in young children. Although the development of a vaccine against RSV is a high priority, no effective vaccine against human RSV is available. Indeed, vaccine development has proceeded with caution following the spectre of vaccine- augmented disease. In a murine model of RSV infection, prior sensitisation with the G protein leads to a Th2 response that is associated with pulmonary eosinophilia, a predominant CD4+ T cell recruitment in broncho-alveolar lavage (BAL) and enhanced illness following RSV challenge. In order to determine if DNA that encodes the G protein (G- DNA) could protect mice from RSV challenge and avoid the Th2-associated pathology, mice were given 3 intramuscular injections of plasmid DNA at weekly intervals. Mice vaccinated with G-DNA had a significantly reduced virus load in their lungs 5 days after RSV challenge compared with control mice. The effect of co-immunisation with DNA encoding the cytokines IL-2 and IL-4 on the immune responses to G-DNA was assessed by comparing RSV-specific antibody isotypes. Mice immunised with GDNA alone had a trend towards IgG1 > IgG2a. This was more pronounced in mice co-immunised with DNA encoding IL-4. In contrast, mice co-immunised with DNA encoding IL-2 had a predominant IgG2a antibody isotype. These data suggest that vaccine-enhanced illness observed following sensitisation with the G protein can be avoided by the use of plasmid DNA that encodes the full-length wild- type protein. Furthermore, DNA encoding plasmids have the ability to modulate the types of immune response induced by proteins encoded on separate plasmid vectors.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file